Filing Details
- Accession Number:
- 0000899243-18-019501
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-05 18:25:52
- Reporting Period:
- 2018-07-03
- Accepted Time:
- 2018-07-05 18:25:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1674416 | Crispr Therapeutics Ag | CRSP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1205703 | J Pablo Cagnoni | C/O Crispr Therapeutics, Inc. 610 Main Street Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2018-07-03 | 5,816 | $5.59 | 5,816 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2018-07-03 | 5,816 | $62.00 | 0 | No | 4 | S | Direct | |
| Common Shares | Acquisiton | 2018-07-05 | 1,684 | $5.59 | 1,684 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2018-07-05 | 1,684 | $62.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Stock Option (Right to Buy) | Acquisiton | 2018-07-03 | 5,816 | $0.00 | 5,816 | $5.59 |
| Common Shares | Stock Option (Right to Buy) | Acquisiton | 2018-07-05 | 1,684 | $0.00 | 1,684 | $5.59 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 88,017 | 2025-11-04 | No | 4 | M | Direct | |
| 86,333 | 2025-11-04 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This option was granted on November 4, 2015 with respect to 93,833 Common Shares with 100% of the shares vesting in 48 equal monthly installments thereafter.
Billionaire Hedge Funds
